{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:21:44Z","timestamp":1782181304154,"version":"3.54.5"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"DOI":"10.1007\/s00108-022-01340-w","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T09:05:46Z","timestamp":1652691946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Funktionelle akrale Durchblutungsst\u00f6rungen","Functional vascular acrosyndromes"],"prefix":"10.1007","author":[{"given":"Peter","family":"Klein-Weigel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Ruttloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Nielitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Steindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta G.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,16]]},"reference":[{"key":"1340_CR1","unstructured":"Raynaud\u00a0M (1862) De l\u2019asphyxie locale et de la gangr\u00e8ne sym\u00e9trique des extr\u00e9mit\u00e9s. Thesis. L. Leclerc, Paris"},{"key":"1340_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1024\/0301-1526\/a000003","volume":"39","author":"H Heidrich","year":"2010","unstructured":"Heidrich\u00a0H (2010) Functional vascular diseases: Raynaud\u2019s syndrome, acrocyanosis and erythromelalgia. Vasa 39:33\u201341","journal-title":"Vasa"},{"key":"1340_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1024\/0301-1526\/a000661","volume":"46","author":"J Belch","year":"2017","unstructured":"Belch\u00a0J, Carlizza\u00a0A, Carpentier\u00a0PH, Constans\u00a0J, Khan\u00a0F, Wautrecht\u00a0JC, Visona\u00a0A, Heiss\u00a0C, Brodeman\u00a0M, P\u00e9csv\u00e1rady\u00a0Z, Roztocil\u00a0K, Colgan\u00a0MP, Vasic\u00a0D, Gotts\u00e4ter\u00a0A, Amann-Vesti\u00a0B, Chraim\u00a0A, Poredo\u0161\u00a0P, Olinic\u00a0DM, Madaric\u00a0J, Nikol\u00a0S, Herrick\u00a0AL, Sprynger\u00a0M, Klein-Weigel\u00a0P, Hafner\u00a0F, Staub\u00a0D, Zeman\u00a0Z (2017) ESVM guidelines\u2014the diagnosis and management of Raynaud\u2019s phenomenon. Vasa 46:413\u2013423","journal-title":"Vasa"},{"key":"1340_CR4","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1024\/0301-1526.37.S73.3","volume":"37","author":"H Heidrich","year":"2008","unstructured":"Heidrich\u00a0H, Helmis\u00a0J, Fahrig\u00a0C, H\u00f6velmann\u00a0R, Martini\u00a0N (2008) Clinical characteristics of primary, secondary and suspected secondary Raynaud\u2019s syndrome and diagnostic transition in the long-term follow-up. A retrospective study in 900\u00a0patients. Vasa 37:S2\u201325","journal-title":"Vasa"},{"key":"1340_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jaut.2014.01.020","volume":"48\u201349","author":"E Maverakis","year":"2014","unstructured":"Maverakis\u00a0E, Patel\u00a0F, Kronenberg\u00a0DG, Chung\u00a0L, Fiorentino\u00a0D, Allanore\u00a0Y, Guiducci\u00a0S, Hesselstrand\u00a0R, Hummers\u00a0LK, Duong\u00a0C, Kahaleh\u00a0B, Macgregor\u00a0A, Matucci-Cerinic\u00a0M, Wollheim\u00a0FA, Mayes\u00a0MD, Gershwin\u00a0ME (2014) International consensus criteria for the diagnosis of Raynaud\u2019s phenomenon. J\u00a0Autoimmun 48\u201349:60\u201365","journal-title":"J Autoimmun"},{"key":"1340_CR6","first-page":"S671","volume":"62","author":"O Sander","year":"2010","unstructured":"Sander\u00a0O, Schroeder\u00a0M, Ostendorf\u00a0B et\u00a0al (2010) Capillary microscopy\u2014a\u00a0crosssectional study in the population. Arthritis Rheum 62:S671\u20132","journal-title":"Arthritis Rheum"},{"key":"1340_CR7","first-page":"879","volume":"24","author":"HR Maricq","year":"1997","unstructured":"Maricq\u00a0HR, Carpentier\u00a0PH, Weinrich\u00a0MC, Keil\u00a0JE, Palesch\u00a0Y, Biro\u00a0C, Vionnet-Fuasset\u00a0M, Jiguet\u00a0M, Valter\u00a0I (1997) Geographic variation in the prevalence of Raynaud\u2019s phenomenon: a\u00a05 region comparison. J\u00a0Rheumatol 24:879\u2013889","journal-title":"J Rheumatol"},{"key":"1340_CR8","doi-asserted-by":"publisher","first-page":"829","DOI":"10.12688\/f1000research.24939.1","volume":"9","author":"C Khouri","year":"2020","unstructured":"Khouri\u00a0C, Roustit\u00a0M, Cracowski\u00a0JL (2020) Impact of global warming on Raynaud\u2019s phenomenon: a\u00a0modelling study. F1000Res 9:829. https:\/\/doi.org\/10.12688\/f1000research.24939.1","journal-title":"F1000Res"},{"key":"1340_CR9","first-page":"273","volume":"118","author":"P Klein-Weigel","year":"2021","unstructured":"Klein-Weigel\u00a0P, Sander\u00a0O, Reinhold\u00a0S, Nielitz\u00a0J, Steindl\u00a0J, Richter\u00a0JG (2021) Raynaud-Ph\u00e4nomen: vaskul\u00e4res Akrosyndrom mit langfristigem Versorgungsbedarf. Dtsch Arztebl Int 118:273\u2013280","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"1340_CR10","doi-asserted-by":"publisher","first-page":"e006389","DOI":"10.1136\/bmjopen-2014-006389","volume":"5","author":"R Garner","year":"2015","unstructured":"Garner\u00a0R, Kumari\u00a0R, Lanyon\u00a0P, Doherty\u00a0M, Zhang\u00a0W (2015) Prevalence, risk factors and associations of primary Raynaud\u2019s phenomenon: systematic review and meta-analysis of observational studies. BMJ Open 5(3):e6389","journal-title":"BMJ Open"},{"key":"1340_CR11","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/art.22626","volume":"57","author":"LF Cherkas","year":"2007","unstructured":"Cherkas\u00a0LF, Williams\u00a0FM, Carter\u00a0L et\u00a0al (2007) Heritability of Raynaud\u2019s phenomenon and vascular responsiveness to cold: a\u00a0study of adult female twins. Arthritis Rheum 57:524\u2013528","journal-title":"Arthritis Rheum"},{"key":"1340_CR12","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/1529-0131(200007)43:7<1641::AID-ANR30>3.0.CO;2-Y","volume":"43","author":"E Susol","year":"2000","unstructured":"Susol\u00a0E, MacGregor\u00a0AJ, Barrett\u00a0JH, Wilson\u00a0H, Black\u00a0C, Welsh\u00a0K, Silman\u00a0A, Ollier\u00a0B, Worthington\u00a0J (2000) A two-stage, genome-wide screen for susceptibility loci in primary Raynaud\u2019s phenomenon. Arthritis Rheum 43:1641\u20131646","journal-title":"Arthritis Rheum"},{"key":"1340_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1177\/000331979504600707","volume":"46","author":"D Greenstein","year":"1995","unstructured":"Greenstein\u00a0D, Gupta\u00a0NK, Martin\u00a0P, Walker\u00a0DR, Kester\u00a0RC (1995) Impaired thermoregulation in Raynaud\u2019s phenomenon. Angiology 46:603\u2013611","journal-title":"Angiology"},{"key":"1340_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1177\/000331979604700501","volume":"47","author":"D Greenstein","year":"1996","unstructured":"Greenstein\u00a0D, Jeffcote\u00a0N, Ilsley\u00a0D, Kester\u00a0RC (1996) The menstrual cycle and Raynaud\u2019s phenomenon. Angiology 47:427\u2013436","journal-title":"Angiology"},{"key":"1340_CR15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.4065\/78.5.603","volume":"78","author":"N Charkoudian","year":"2003","unstructured":"Charkoudian\u00a0N (2003) Skin blood flow in adult human thermoregulation: how it works, when it does not, and why. Mayo Clin Proc 78:603\u2013612","journal-title":"Mayo Clin Proc"},{"key":"1340_CR16","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1177\/000331979604700501","volume":"47","author":"D Greenstein","year":"1996","unstructured":"Greenstein\u00a0D, Jeffcote\u00a0N, Ilsley\u00a0D, Kester\u00a0RC (1996) The menstrual cycle and Raynaud\u2019s phenomenon. Angiology 47:427\u2013436","journal-title":"Angiology"},{"key":"1340_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nrrheum.2014.195","volume":"11","author":"NA Flavahan","year":"2015","unstructured":"Flavahan\u00a0NA (2015) A vascular mechanistic approach to understanding Raynaud\u2019s phenomenon. Nat Rev Rheumatol 11:146\u2013158","journal-title":"Nat Rev Rheumatol"},{"key":"1340_CR18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0950-821X(05)80688-7","volume":"5","author":"S Singh","year":"1991","unstructured":"Singh\u00a0S, de Trafford\u00a0JC, Baskerville\u00a0PA et\u00a0al (1991) Digital artery calibre measurement\u2014a new technique of assessing Raynaud\u2019s phenomenon. Eur J Vasc Surg 5:199\u2013203","journal-title":"Eur J Vasc Surg"},{"key":"1340_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/rheumatology\/29.3.181","volume":"29","author":"D Walmsley","year":"1990","unstructured":"Walmsley\u00a0D, Goodfield\u00a0MJ (1990) Evidence for an abnormal peripherally mediated vascular response to temperature in Raynaud\u2019s phenomenon. Br J Rheumatol 29:181\u2013184","journal-title":"Br J Rheumatol"},{"key":"1340_CR20","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1161\/01.RES.0000128407.45014.58","volume":"94","author":"SR Bailey","year":"2004","unstructured":"Bailey\u00a0SR, Eid\u00a0AH, Mitra\u00a0S, Flavahan\u00a0S, Flavahan\u00a0NA (2004) Rho kinase mediates cold-induced constriction of cutaneous arteries: role of alpha2C-adrenoceptor translocation. Circ Res 94:1367\u20131374","journal-title":"Circ Res"},{"key":"1340_CR21","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/0140-6736(90)92766-B","volume":"336","author":"MR Zamora","year":"1990","unstructured":"Zamora\u00a0MR, O\u2019Brien\u00a0RF, Rutherford\u00a0RB, Weil\u00a0JV (1990) Serum endothelin\u20111 concentrations and cold provocation in primary Raynaud\u2019s phenomenon. Lancet 336:1144\u20131147","journal-title":"Lancet"},{"key":"1340_CR22","first-page":"221","volume":"25","author":"W Rychlik-Golema","year":"2006","unstructured":"Rychlik-Golema\u00a0W, Mastej\u00a0K, Adamiec\u00a0R (2006) The role of endothelin\u20111 and selected cytokines in the pathogenesis of Raynaud\u2019s phenomenon associated with systemic connective tissue diseases. Int Angiol 25:221\u2013227","journal-title":"Int Angiol"},{"key":"1340_CR23","first-page":"17","volume":"30","author":"MI Spengler","year":"2004","unstructured":"Spengler\u00a0MI, Svetaz\u00a0MJ, Leroux\u00a0MB, Leiva\u00a0ML, Bottai\u00a0HM (2004) Association between capillaroscopy, haemorheological variables and plasma proteins in patients bearing Raynaud\u2019s phenomenon. Clin Hemorheol Microcirc 30:17\u201324","journal-title":"Clin Hemorheol Microcirc"},{"key":"1340_CR24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1365-2796.1990.tb00224.x","volume":"228","author":"J Leppert","year":"1990","unstructured":"Leppert\u00a0J, Aberg\u00a0H, Levin\u00a0K, Ringqvist\u00a0I (1990) Lower serum magnesium level after exposure to cold in women with primary Raynaud\u2019s phenomenon. J\u00a0Intern Med 228:235\u2013239","journal-title":"J Intern Med"},{"key":"1340_CR25","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.vph.2014.09.003","volume":"63","author":"D Kundu","year":"2014","unstructured":"Kundu\u00a0D, Abraham\u00a0D, Black\u00a0CM, Denton\u00a0CP, Bruckdorfer\u00a0KR (2014) Reduced levels of S\u2011nitrosothiols in plasma of patients with systemic sclerosis and Raynaud\u2019s phenomenon. Vasc Pharmacol 63:178\u2013181","journal-title":"Vasc Pharmacol"},{"key":"1340_CR26","first-page":"2499","volume":"86","author":"NN Chan","year":"2001","unstructured":"Chan\u00a0NN, MacAllister\u00a0RJ, Colhoun\u00a0HM, Vallance\u00a0P, Hingorani\u00a0AD (2001) Changes in endothelium-dependent vasodilatation and alphaadrenergic responses in resistance vessels during the menstrual cycle in healthy women. J\u00a0Clin Endocrinol Metab 86:2499\u20132504","journal-title":"J Clin Endocrinol Metab"},{"key":"1340_CR27","doi-asserted-by":"publisher","first-page":"H1105","DOI":"10.1152\/ajpheart.00645.2013","volume":"306","author":"T Li","year":"2014","unstructured":"Li\u00a0T, Xiao\u00a0X, Zhang\u00a0J, Zhu\u00a0Y, Hu\u00a0Y, Zang\u00a0J, Lu\u00a0K, Yang\u00a0T, Ge\u00a0H, Peng\u00a0X, Lan\u00a0D, Liu\u00a0L (2014) Age and sex differences in vascular responsiveness in healthy and trauma patients: contribution of estrogen receptor-mediated Rho kinase and PKC pathways. Am J Physiol Heart Circ Physiol 306:H1105\u2013H1115","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1340_CR28","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1001\/archinte.158.6.595","volume":"158","author":"G Spencer-Green","year":"1998","unstructured":"Spencer-Green\u00a0G (1998) Outcomes in primary Raynaud phenomenon: a\u00a0meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 158:595\u2013600","journal-title":"Arch Intern Med"},{"key":"1340_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jmv.2012.05.005","volume":"37","author":"MA Pistorius","year":"2012","unstructured":"Pistorius\u00a0MA, Carpentier\u00a0PH, le groupe de travail \u00abMicrocirculation\u00bb de la Soci\u00e9t\u00e9 fran\u00e7aise de m\u00e9decine vasculaire (2012) Bilan \u00e9tiologique minimal du ph\u00e9nom\u00e8ne de Raynaud : un consensus d\u2019experts [Minimal work-up for Raynaud syndrome: a\u00a0consensus report. Microcirculation Working Group of the French Vascular Medicine Society]. J\u00a0Mal Vasc 37:207\u2013212","journal-title":"J Mal Vasc"},{"key":"1340_CR30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11926-015-0506-3","volume":"17","author":"SR Johnson","year":"2015","unstructured":"Johnson\u00a0SR (2015) New ACR EULAR guidelines for systemic sclerosis classification. Curr Rheumatol Rep 17:32","journal-title":"Curr Rheumatol Rep"},{"key":"1340_CR31","first-page":"195","volume":"1","author":"H Maricq","year":"1983","unstructured":"Maricq\u00a0H, Harper\u00a0F, Khan\u00a0M, Tan\u00a0E, LeRoy\u00a0E (1983) Microvascular abnormalities as possible predictors of disease subset in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1:195\u2013205","journal-title":"Clin Exp Rheumatol"},{"key":"1340_CR32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2174\/157339710904140417125010","volume":"9","author":"M Cutolo","year":"2013","unstructured":"Cutolo\u00a0M, Pizzorni\u00a0C, Sulli\u00a0A et\u00a0al (2013) Early diagnostic and predictive value of capillaroscopy in systemic sclerosis. Curr Rheumatol Rev 9:249\u2013253","journal-title":"Curr Rheumatol Rev"},{"key":"1340_CR33","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1002\/art.24038","volume":"58","author":"M Koenig","year":"2008","unstructured":"Koenig\u00a0M, Joyal\u00a0F, Fritzler\u00a0MJ et al (2008) Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud\u2019s phenomenon to systemic sclerosis: a\u00a0twenty-year prospective study of 586\u00a0patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 58:3902\u20133912","journal-title":"Arthritis Rheum"},{"key":"1340_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000467.pub2","author":"F Rirash","year":"2017","unstructured":"Rirash\u00a0F, Tingey\u00a0PC, Harding\u00a0SE et\u00a0al (2017) Calcium channel blockers for primary and secondary Raynaud\u2019s phenomenon. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD000467.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"1340_CR35","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1002\/1529-0131(199912)42:12<2646::AID-ANR21>3.0.CO;2-T","volume":"42","author":"M Dziadzio","year":"1999","unstructured":"Dziadzio\u00a0M, Denton\u00a0CP, Smith\u00a0R et al (1999) Losartan therapy for Raynaud\u2019s phenomenon and scleroderma: clinical and biochemical findings in a\u00a0fifteen-week, randomized, parallel-group, controlled trial. Arthritis Rheum 42:2646\u20132655","journal-title":"Arthritis Rheum"},{"key":"1340_CR36","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1136\/annrheumdis-2012-202836","volume":"72","author":"M Roustit","year":"2013","unstructured":"Roustit\u00a0M, Blaise\u00a0S, Allanore\u00a0Y et al (2013) Phosphodiesterase\u20115 inhibitors for the treatment of secondary Raynaud\u2019s phenomenon: systematic review and meta-analysis of randomised trials. Ann Rheum Dis 72:1696\u20131699","journal-title":"Ann Rheum Dis"},{"key":"1340_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000953","author":"J Pope","year":"1998","unstructured":"Pope\u00a0J, Fenlon\u00a0D, Thompson\u00a0A et\u00a0al (1998) Iloprost and cisaprost for Raynaud\u2019s phenomenon in progressive systemic sclerosis. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD000953","journal-title":"Cochrane Database Syst Rev"},{"key":"1340_CR38","first-page":"503","volume":"19","author":"R Scorza","year":"2001","unstructured":"Scorza\u00a0R, Caronni\u00a0M, Mascagni\u00a0B et al (2001) Effects of long-term cyclic iloprost therapy in systemic sclerosis with Raynaud\u2019s phenomenon. A randomized, controlled study. Clin Exp Rheumatol 19:503\u2013508","journal-title":"Clin Exp Rheumatol"},{"key":"1340_CR39","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","volume":"76","author":"O Kowal-Bielecka","year":"2017","unstructured":"Kowal-Bielecka\u00a0O, Fransen\u00a0J, Avouac\u00a0J et al (2017) Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis 76:1327\u20131339","journal-title":"Ann Rheum Dis"},{"key":"1340_CR40","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s40261-018-0698-1","volume":"38","author":"M Huntgeburth","year":"2018","unstructured":"Huntgeburth\u00a0M, Kie\u00dfling\u00a0J, Weimann\u00a0G, Wilberg\u00a0V, Saleh\u00a0S, Hunzelmann\u00a0N, Rosenkranz\u00a0S (2018) Riociguat for the treatment of Raynaud\u2019s phenomenon: a single-dose, double-blind, randomized, placebo-controlled cross-over pilot study (DIGIT). Clin Drug Investig 38:1061\u20131069","journal-title":"Clin Drug Investig"},{"key":"1340_CR41","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1002\/art.40123","volume":"69","author":"RJ Bello","year":"2017","unstructured":"Bello\u00a0RJ, Cooney\u00a0CM, Melamed\u00a0E, Follmar\u00a0K, Yenokyan\u00a0G, Leatherman\u00a0G, Shah\u00a0AA, Wigley\u00a0FM, Hummers\u00a0LK, Lifchez\u00a0SD (2017) The therapeutic efficacy of Botulinum toxin in treating scleroderma-associated Raynaud\u2019s phenomenon: a randomized, double-blind, placebo-controlled clinical trial. Arthritis Rheumatol 69:1661\u20131669","journal-title":"Arthritis Rheumatol"},{"key":"1340_CR42","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/1346-8138.14140","volume":"45","author":"SI Motegi","year":"2018","unstructured":"Motegi\u00a0SI, Sekiguchi\u00a0A, Saito\u00a0S, Ishibuchi\u00a0H, Kishi\u00a0C, Yasuda\u00a0M, Ishikawa\u00a0O (2018) Successful treatment of Raynaud\u2019s phenomenon and digital ulcers in systemic sclerosis patients with botulinum toxin B injection: Assessment of peripheral vascular disorder by angiography and dermoscopic image of nail fold capillary. J\u00a0Dermatol 45:349\u2013352","journal-title":"J Dermatol"},{"key":"1340_CR43","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1177\/1358863X11398519","volume":"16","author":"AK Kurklinsky","year":"2011","unstructured":"Kurklinsky\u00a0AK, Miller\u00a0VM, Rooke\u00a0T (2011) Acrocyanosis: the flying dutchman. Vasc Med 16:288\u2013301","journal-title":"Vasc Med"},{"key":"1340_CR44","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3889\/oamjms.2018.035","volume":"6","author":"U Wollina","year":"2018","unstructured":"Wollina\u00a0U, Koch\u00a0A, Langner\u00a0D et\u00a0al (2018) Acrocyanosis\u2014a symptom with many facettes. Open Access Maced J Med Sci 6:208\u2013212","journal-title":"Open Access Maced J Med Sci"},{"key":"1340_CR45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1067\/mjd.2002.120474","volume":"47","author":"E Poszepczynska-Guign\u00e9","year":"2002","unstructured":"Poszepczynska-Guign\u00e9\u00a0E, Viguier\u00a0C, Orcel\u00a0B et al (2002) Paraneoplastic acral vascular syndrome: epidemiologic features, clinical manifestations, and disease sequelae. JAAD 47:47\u201352","journal-title":"JAAD"},{"key":"1340_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.mvr.2016.09.001","volume":"109","author":"Z Emrani","year":"2017","unstructured":"Emrani\u00a0Z, Karbalaie\u00a0A, Fatemi\u00a0A, Etehadtavakol\u00a0M, Erlandsson\u00a0B\u2011E (2017) Capillary density. An important parameter in nailfold capillaroscopy. Microvasc Res 109:7\u201318","journal-title":"Microvasc Res"},{"key":"1340_CR47","series-title":"Medizinwelt. Innere Medizin","volume-title":"Funktionelle Gef\u00e4\u00dferkrankungen","author":"P Klein-Weigel","year":"2021","unstructured":"Klein-Weigel\u00a0P (2021) Funktionelle Gef\u00e4\u00dferkrankungen. Medizinwelt. Innere Medizin. Elsevier"},{"key":"1340_CR48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0022-3999(03)00381-7","volume":"56","author":"P Klein-Weigel","year":"2004","unstructured":"Klein-Weigel\u00a0P, Rein\u00a0P, Kronenberg\u00a0F, List\u00a0E, Kinzl\u00a0J, Biebl\u00a0W, Fraedrich\u00a0G (2004) Microcirculatory assessment of vascular acrosyndrome in anorexia nervosa and analysis of manifestation factors. J\u00a0Psychosom Res 56:145\u2013148","journal-title":"J Psychosom Res"},{"key":"1340_CR49","first-page":"2","volume":"76","author":"SW Mitchell","year":"1878","unstructured":"Mitchell\u00a0SW (1878) On a\u00a0rare vaso-motor neurosis of the extremities and on the maladies with which it may occur. Am J Med Sci 76:2\u201336","journal-title":"Am J Med Sci"},{"key":"1340_CR50","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1024\/0301-1526\/a000675","volume":"47","author":"PF Klein-Weigel","year":"2018","unstructured":"Klein-Weigel\u00a0PF, Volz\u00a0TS, Richter\u00a0JG (2018) Erythromelalgia. Vasa 47:91\u201397","journal-title":"Vasa"},{"key":"1340_CR51","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/ced.13891","volume":"44","author":"N Mann","year":"2019","unstructured":"Mann\u00a0N, King\u00a0T, Murphy\u00a0R (2019) Review of primary and secondary erythromelalgia. Clin Exp Dermatol 44:477\u2013482","journal-title":"Clin Exp Dermatol"},{"key":"1340_CR52","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jaad.2013.02.021","volume":"69","author":"MD Davis","year":"2013","unstructured":"Davis\u00a0MD (2013) Immersion foot associated with the overuse of ice, cold water, and fans: a\u00a0distinctive clinical presentation complicating the syndrome of erythromelalgia. J\u00a0Am Acad Dermatol 69:169\u2013171","journal-title":"J Am Acad Dermatol"},{"key":"1340_CR53","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/archderm.136.3.330","volume":"136","author":"MDP Davis","year":"2000","unstructured":"Davis\u00a0MDP, O\u2019Fallon\u00a0WM, Rogers\u00a0RS III, Rooke\u00a0TW (2000) Natural history of erythromelalgia. Arch Dermatol 136:330\u2013336","journal-title":"Arch Dermatol"},{"key":"1340_CR54","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11910-011-0233-8","volume":"12","author":"R Dabby","year":"2012","unstructured":"Dabby\u00a0R (2012) Pain disorders and erythromelalgia caused by voltage-gated sodium channel mutations. Curr Neurol Neurosci Rep 12:76\u201383","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1340_CR55","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1468-3083.2008.02938.x","volume":"23","author":"KB Reed","year":"2009","unstructured":"Reed\u00a0KB, Davis\u00a0MD (2009) Incidence of erythromelalgia: a\u00a0population-based study in Olmsted County, Minnesota. J\u00a0Eur Acad Dermatol Venereol 23:13\u201315","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1340_CR56","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1024\/0301-1526\/a000162","volume":"41","author":"A Alhadad","year":"2012","unstructured":"Alhadad\u00a0A, Wollmer\u00a0P, Svensson\u00a0A, Eriksson\u00a0KF (2012) Erythromelalgia: incidence and clinical experience in a\u00a0single centre in Sweden. Vasa 41:43\u201348","journal-title":"Vasa"},{"key":"1340_CR57","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1136\/jmg.2003.012153","volume":"41","author":"Y Yang","year":"2004","unstructured":"Yang\u00a0Y, Wang\u00a0Y, Li\u00a0S, Xu\u00a0Z, Li\u00a0H, Ma\u00a0L, Fan\u00a0J, Bu\u00a0D, Liu\u00a0B, Fan\u00a0Z, Wu\u00a0G, Jin\u00a0J, Ding\u00a0B, Zhu\u00a0X, Shen\u00a0Y (2004) Mutations in SCN9A, encoding a\u00a0sodium channel alpha subunit, in patients with primary erythermalgia. J\u00a0Med Genet 41:171\u2013174","journal-title":"J Med Genet"},{"key":"1340_CR58","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13023-015-0347-1","volume":"10","author":"Z Tang","year":"2015","unstructured":"Tang\u00a0Z, Chen\u00a0Z, Tang\u00a0B, Jiang\u00a0H (2015) Primary erythromelalgia: a\u00a0review. Orphanet J Rare Dis 10:127","journal-title":"Orphanet J Rare Dis"},{"key":"1340_CR59","doi-asserted-by":"publisher","first-page":"e1002561","DOI":"10.1371\/journal.pbio.1002561","volume":"14","author":"CW Huang","year":"2016","unstructured":"Huang\u00a0CW, Lai\u00a0HJ, Huang\u00a0PY, Lee\u00a0MJ, Kuo\u00a0CC (2016) The biophysical basis underlying gating changes in the p.V1316A mutant Nav1.7 channel and the molecular pathogenesis of inherited erythromelalgia. PLoS Biol 14:e1002561","journal-title":"PLoS Biol"},{"key":"1340_CR60","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1744-8069-7-92","volume":"7","author":"M Estacion","year":"2011","unstructured":"Estacion\u00a0M, Han\u00a0C, Choi\u00a0JS, Hoeijmakers\u00a0JG, Lauria\u00a0G, Drenth\u00a0JP, Gerrits\u00a0MM, Dib-Hajj\u00a0SD, Faber\u00a0CG, Merkies\u00a0IS, Waxman\u00a0SG (2011) Intra- and interfamily phenotypic diversity in pain syndromes associated with a\u00a0gain-of-function variant of NaV1.7. Mol Pain 7:92","journal-title":"Mol Pain"},{"issue":"Pt 3","key":"1340_CR61","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1113\/jphysiol.2006.127027","volume":"581","author":"PL Sheets","year":"2007","unstructured":"Sheets\u00a0PL, Jackson\u00a0JO 2nd, Waxman\u00a0SG, Dib-Hajj\u00a0SD, Cummins\u00a0TR (2007) A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity. J\u00a0Physiol 581(Pt 3):1019\u20131031","journal-title":"J Physiol"},{"key":"1340_CR62","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/RHU.0b013e31829cf8a2","volume":"19","author":"K Kalava","year":"2013","unstructured":"Kalava\u00a0K, Roberts\u00a0C, Adair\u00a0JD, Raman\u00a0V (2013) Response of primary erythromelalgia to pregabalin therapy. J\u00a0Clin Rheumatol 19:284\u2013285","journal-title":"J Clin Rheumatol"},{"key":"1340_CR63","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1159\/000345377","volume":"4","author":"A Kakizaki","year":"2012","unstructured":"Kakizaki\u00a0A, Fujimura\u00a0T, Kambayashi\u00a0Y, Watabe\u00a0A, Aiba\u00a0S (2012) Successful treatment of adult-onset erythromelalgia with steroid pulse and pregabalin. Case Rep Dermatol 4:242\u2013246","journal-title":"Case Rep Dermatol"},{"key":"1340_CR64","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jaad.2016.08.048","volume":"76","author":"GL Pagani-Est\u00e9vez","year":"2017","unstructured":"Pagani-Est\u00e9vez\u00a0GL, Sandroni\u00a0P, Davis\u00a0MD, Watson\u00a0JC (2017) Erythromelalgia: Identification of a\u00a0corticosteroid-responsive subset. J\u00a0Am Acad Dermatol 76:506\u2013511","journal-title":"J Am Acad Dermatol"},{"key":"1340_CR65","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1080\/00015550310015031","volume":"83","author":"OM Kalgaard","year":"2003","unstructured":"Kalgaard\u00a0OM, M\u00f8rk\u00a0C, Kvernebo\u00a0K (2003) Prostacyclin reduces symptoms and sympathetic dysfunction in erythromelalgia in a\u00a0double-blind randomized pilot study. Acta Derm Venereol 83:442\u2013444","journal-title":"Acta Derm Venereol"},{"key":"1340_CR66","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.0022-202X.2004.22339.x","volume":"122","author":"C M\u00f8rk","year":"2004","unstructured":"M\u00f8rk\u00a0C, Salerud\u00a0EG, Asker\u00a0CL, Kvernebo\u00a0K (2004) The prostaglandin E1 analog misoprostol reduces symptoms and microvascular arteriovenous shunting in erythromelalgia\u2014a\u00a0double-blind, crossover, placebo-compared study. J\u00a0Invest Dermatol 122:587\u2013593","journal-title":"J Invest Dermatol"},{"issue":"Suppl 1","key":"1340_CR67","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1097\/j.pain.0000000000000854","volume":"158","author":"SD Dib-Hajj","year":"2017","unstructured":"Dib-Hajj\u00a0SD, Geha\u00a0P, Waxman\u00a0SG (2017) Sodium channels in pain disorders: pathophysiology and prospects for treatment. Pain 158(Suppl 1):S97\u2013S107","journal-title":"Pain"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-022-01340-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-022-01340-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-022-01340-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T10:03:12Z","timestamp":1652695392000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-022-01340-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,16]]},"references-count":67,"alternative-id":["1340"],"URL":"https:\/\/doi.org\/10.1007\/s00108-022-01340-w","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,16]]},"assertion":[{"value":"25 April 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"P.\u00a0Klein-Weigel, A.\u00a0Ruttloff, D.\u00a0K\u00f6nig, J.\u00a0Nielitz, J.\u00a0Steindl, O.\u00a0Sander und J.G.\u00a0Richter geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}